Skip to content
  • About
  • Capabilities
  • Who We Are
  • Track Record
  • Careers
  • Case Study
  • News
  • Contact Us
  • About
  • Capabilities
  • Who We Are
  • Track Record
  • Careers
  • Case Study
  • News
  • Contact Us
Contact Us
Contact Us
  • About
  • Capabilities
  • Who We Are
  • Track Record
  • Careers
  • Case Study
  • News
  • Contact Us
  • About
  • Capabilities
  • Who We Are
  • Track Record
  • Careers
  • Case Study
  • News
  • Contact Us

Author: Dto3Admin

14/12/2024: D23 Announces The Sale Of Volpara (VHT.ASX) To Lunit In Korea For A$296m​

D23 was the exclusive financial advisor to Volpara.

13/3/2024: Volpara Releases Scheme Implementation Booklet and Sets Shareholder Vote for April 12th 2024

In Relation To The Proposed Acquisition Of All Of The Fully Paid Ordinary Shares In Volpara Health Technologies……

30/11/2023: D23 Hires Technology Banker Vasili Hatzis from Goldman Sachs with Extensive USA Technology Banking Experience

Wellington, NZ, 14 December 2023: Volpara Health Technologies Limited (“Volpara”, “The Group,” Or “The…

D23 Capital provides high quality, and objective advice to retained clients across the full spectrum of M&A transactions

Newsletter Signup

Quick Links

  • About
  • Capabilities
  • Who We Are
  • Track Record
  • Careers
  • Case Study
  • News

industries we serve

  • Technology
  • Financial
  • Transport & Logistics
  • Healthcare
  • Education

Get In Touch

  • james@d23capital.com
  • 61 417 885 885
  • Lorem Ipsum Is Dummy Text Address

© 2023 by d23Capital | Designed by Mindpath. all rights reserved